nci_id,nct_id,official_title,inclusion_indicaInclusionor,description,Text,NCIT,English Text,UMLS CUI,UMLS CUI (eng),SNOMED_CT,SNOMED_CT (eng),ICD10CM,ICD10CM (eng),LOINC,LOINC (eng)NCI-2009-00817,NCT00001337,Dose-Adjusted EPOCH Chemotherapy and Rituximab (Cd20+) in Adults and Children with Previously Untreated Aggressive Non-Hodgkin's Lymphoma,Inclusion,Human immunodeficiency virus (HIV) negative,HIV excluded OR HIV UNKNOWN,C15175 = NO OR C15175=C17998,'HIV Positivity' = NO OR 'HIV Positivity'='Unknown',,,278977008 = NO OR 278977008=261665006,'HIV status' = NO OR 'HIV status'='Unknown',Z71.7 = NO OR Z71.7=N27,Human immunodeficiency virus [HIV] counseling' = NO OR 'Human immunodeficiency virus [HIV] counseling'='Small kidney of unknown cause',LP183501-8 = NO OR LP183501-8=LA4489-6,'HIV' = NO OR 'HIV'='Unknown'NCI-2011-00312,NCT01012817,"A Phase 1/2 Trial of ABT-888, an Inhibitor of Poly(ADP-ribose) Polymerase (PARP), and Topotecan (TPT) in Patients with Solid Tumors (Phase 1) and Relapsed Ovarian Cancer or Primary Peritoneal Cancer (Phase 2) after Prior Platinum Containing First-Line Chemotherapy",Exclusion,Immunocompromised patients (other than that related to the use of corticosteroids) including patients known to be human immunodeficiency virus (HIV) positive,HIV negative included:  Immunocompromised excluded (unless due to corticosteroid usage),C14139 = NO OR (C14139=NO AND C211=YES) AND (C15175 = NO OR C15175=C17998) ,'Immunocompromised  ' = NO OR ('Immunocompromised  '=NO AND 'Therapeutic Corticosteroid'=YES) AND ('HIV Positivity' = NO OR 'HIV Positivity'='Unknown') ,,,370388006 = NO OR (370388006=NO AND 363733008=YES) AND (278977008 = NO OR 278977008=261665006) ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,